Investing in turnaround stories can offer significant rewards, but not all struggling companies are poised for a comeback!
In E41, Krzysztof highlights how Coherus Biosciences $CHRS could offer market beating returns from the current 📉 valuation - it was enough to convince Luke to buy
Wall Street Wildlife Investing Podcast